![Tikcro technologies](/api/images/company-pic/default.png)
Contáctenos
Acerca de la compañía
Tikcro develops and distributes biotechnology technologies for its clients. The company’s early stage pipeline consists of CTLA-4 antibody, PD1, antibody, PDL1, PDL2, and TIGIT. Furthermore, it develops and distributes 3D antigen design technologies that generates functional antibodies for its clients. Tikcro was founded in 1999 and is based in Ra’anana.
IL
Desconocido
Empresa no verificada
Transparencia empresarial
- No verificó la información de la empresa
- Pide reseñas a sus clientes
- No respondió a las críticas negativas.